The impact of multi-modal therapy on survival for uterine carcinosarcomas

Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium

S. Pecorelli · International Journal of Gynecology & Obstetrics · 2009 · 2.9K citations

Medicine, Gynecology, Oncology +10

An Immunohistochemical Study

Peter G. Isaacson, Ahmet Doǧan, Stephen K. Price et al. · The American Journal of Surgical Pathology · 1989 · 1.9K citations

Medicine, Endocrinology, Pathology +13

Surveillance, Epidemiology, and End Results analysis of 2677 cases of uterine sarcoma 1989–1999

Sandra E. Brooks, Min Zhan, Timothy R. Coté et al. · Gynecologic Oncology · 2004 · 522 citations

Medicine, Oncology, Surgery +10

Phase III Trial of Ifosfamide With or Without Paclitaxel in Advanced Uterine Carcinosarcoma: A Gynecologic Oncology Group Study

Howard D. Homesley, Virginia L. Filiaci, Maurie Markman et al. · Journal of Clinical Oncology · 2007 · 262 citations · Full text

Medicine, Oncology, Pharmacology +10

A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I–IV carcinosarcoma (CS) of the uterus☆

Aaron H. Wolfson, M. Brady, Thomas F. Rocereto et al. · Gynecologic Oncology · 2007 · 258 citations · Full text

Medicine, Oncology, Radiation Oncology +8